Edition:
United States

Celgene Corp (CELG.OQ)

CELG.OQ on NASDAQ Stock Exchange Global Select Market

94.83USD
12:30pm EST
Change (% chg)

$-0.43 (-0.45%)
Prev Close
$95.26
Open
$94.79
Day's High
$95.39
Day's Low
$94.25
Volume
658,350
Avg. Vol
2,751,972
52-wk High
$147.13
52-wk Low
$88.34

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark Alles

58 2018 Chairman of the Board, Chief Executive Officer

Scott Smith

55 2017 President, Chief Operating Officer

Peter Kellogg

61 2014 Chief Financial Officer, Executive Vice President

Terrie Curran

48 2017 President, Global Inflammation & Immunology Franchise

Michael Pehl

52 2016 President, Hematology & Oncology